Yangbing Zhao, MD, PhD
Director, T Cell Engineering Laboratory Associate Professor, Surgery
Dr. Yangbing Zhao is currently the Director of the TCEL at the Abramson Cancer Center and Adjunct Associate Professor in the Department of Pathology & Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. He is a graduate of the Third Medical University in Chongqing, China, where he received his PhD and MD. He was a postdoctoral student and visiting scientist at The Weizmann Institute of Science in Rehovot, Israel, from 1996 - 2000 where he studied tolerance induction through genetically engineered T cells for allogeneic bone marrow transplantation. For the next two years he was a research associate at Duke University Medical Center in Durham, North Carolina, where he worked on RNA transfected dendritic cell vaccines against tumors. Next, he was a senior research fellow at the Surgery Branch of the National Cancer Institute at the U.S. National Institutes of Health from 2003 - 2008 where he developed NY-ESO-1 TCR and Her2/Neu CAR transduced T cells into clinical trials. From there, he joined The Translational Research Program under Dr. Carl June where he became the director of the TCEL and developed multiple CARs against solid tumors into clinical trials.
Dr. Zhao is interested in improving T cell based cancer immunotherapy through modifying T cells through gene transfer and gene editing.
Adjunct Associate Professor
Department of Pathology and Laboratory Medicine
University of Pennsylvania School of Medicine
Smilow Center for Translational Research
Building 421, RM08-122
3400 Civic Center Blvd.
Philadelphia, Pa 19104-5156
(215) 746-7618 phone